Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/22/1998US5851822 Inflammation-induced expression of a recombinant gene
12/22/1998US5851815 MCH4 and MCH5, apoptotic proteases
12/22/1998US5851814 Human elastate IV
12/22/1998US5851812 IKK-β proteins, nucleic acids and methods
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851806 Complementary adenoviral systems and cell lines
12/22/1998US5851802 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
12/22/1998US5851801 Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions
12/22/1998US5851800 Process for producing a protein
12/22/1998US5851799 Histone-like protein
12/22/1998US5851798 Nucleic acid encoding human GPR14 receptor
12/22/1998US5851797 Tie ligand-3, methods of making and uses thereof
12/22/1998US5851795 Soluble CTLA4 molecules and uses thereof
12/22/1998US5851794 Collagen binding protein as well as its preparation
12/22/1998US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998US5851787 Nucleic acid encoding amyloid precursor-like protein and uses thereof
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851784 Human phosphodiesterase type IVC, and its production and use
12/22/1998US5851775 β-catenin, Tcf-4, and APC interact to prevent cancer
12/22/1998US5851774 Human MLF3 protein
12/22/1998US5851764 Human prostate tumor inducing gene-1 and uses thereof
12/22/1998US5851636 Ceramic packing with channels for thermal and catalytic beds
12/22/1998US5851531 Adult-onset diabetes treatment method
12/22/1998US5851529 Recombinant retroviruses
12/22/1998US5851528 Methods of inhibiting complement activation
12/22/1998US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998US5851525 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
12/22/1998US5851524 Human monoclonal anti-rhesus (D) antibodies and cell lines producing same
12/22/1998US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
12/22/1998US5851522 Enhancing keratinocyte migration
12/22/1998US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
12/22/1998CA2126699C An iron-containing composition for the prevention of anaemia and a method for producing the composition
12/22/1998CA1340281C Process for preparing and purifying alpha-interferon
12/20/1998CA2235444A1 Novel compounds
12/20/1998CA2235442A1 Response regulator
12/20/1998CA2235441A1 Novel compounds
12/20/1998CA2235437A1 Novel compounds
12/20/1998CA2235435A1 Novel compounds
12/20/1998CA2235433A1 Novel compounds
12/20/1998CA2235422A1 Novel compounds
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/18/1998CA2234414A1 Cdna clone heoad54 that encodes a human 7 transmembrane receptor
12/17/1998WO1998057175A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
12/17/1998WO1998057174A1 Synthetic antibiotics
12/17/1998WO1998056938A1 Lipoproteins as nucleic acid vectors
12/17/1998WO1998056936A1 Regulatory sequences involved in hypoxia regulated gene expression and uses thereof
12/17/1998WO1998056925A1 Human protein phosphatase ii-c-like protein
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056916A1 Aprotinin variants with improved properties and bikunins of aprotinin variants
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056912A1 Human formin binding protein
12/17/1998WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998056907A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof
12/17/1998WO1998056906A1 Trimerising module
12/17/1998WO1998056905A1 Oligonucleotide derivatives
12/17/1998WO1998056898A2 Human peroxisomal thioesterase
12/17/1998WO1998056892A1 Human tumor necrosis factor receptor tr9
12/17/1998WO1998056821A1 Alpha 1-antitrypsin preparation and method for the production thereof
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056819A1 Methods of regulating t cell and macrophage cytokine production, function and pathogenicity
12/17/1998WO1998056818A1 Human l105 proteins and polynucleotides encoding same
12/17/1998WO1998056817A1 Composition and methods for the treatment of inflammatory diseases
12/17/1998WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/17/1998WO1998056813A2 Two human membrane-fusion proteins
12/17/1998WO1998056812A2 Estrogen receptor crystals and ligands
12/17/1998WO1998056810A2 Lus-1 human protein, its production and use
12/17/1998WO1998056809A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same
12/17/1998WO1998056806A1 A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP
12/17/1998WO1998056804A1 86 human secreted proteins
12/17/1998WO1998056426A1 Controlled release microencapsulated ngf formulation
12/17/1998WO1998056421A1 Method for preventing hiv-1 infection of cd4+ cells
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998WO1998056411A1 Novel antimicrobial polypeptide and methods of use
12/17/1998WO1998056410A1 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence
12/17/1998WO1998056409A1 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS
12/17/1998WO1998056408A2 Inhibitors of microbial adherence or invasion as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056407A2 Fibronectin antagonists as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056406A1 Stable insulin formulations
12/17/1998WO1998056405A1 A method of modulating immune response with osteopontin
12/17/1998WO1998056404A1 Cns neuroregenerative compositions and methods of use
12/17/1998WO1998056403A1 Improvement of the regeneration of myelin sheaths
12/17/1998WO1998056402A1 Oral formulations for treatment of bacteria-induced diseases of the colon
12/17/1998WO1998056401A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
12/17/1998WO1998056400A1 Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides
12/17/1998WO1998056398A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
12/17/1998WO1998056396A1 Adult-onset diabetes treatment method
12/17/1998WO1998056394A1 Compositions useful as fibrin sealants
12/17/1998WO1998056393A1 Transplantation of immortalized dopamine cells to improve neurological deficits
12/17/1998WO1998056391A1 Methods for treating human cancers
12/17/1998WO1998056355A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998WO1998056248A1 A novel method of detecting and treating cancer
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998047917A3 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
12/17/1998WO1998045319A3 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN α-CATENIN and β-CATENIN
12/17/1998WO1998041652A3 Dna for detecting changes in chromosome 7
12/17/1998WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/17/1998WO1998040087A3 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
12/17/1998WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
1 ... 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 ... 3163